Atlas Trials

Bionoxx Inc.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Bionoxx Inc.

RecordFirmDate
A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea) (NCT07190833)Bionoxx Inc.2026-03-09
A Single-volunteer Study of Immune Response Following OTS-412 Vaccinia Virus Systemic Injection(Self-experiment) (NCT07302945)Bionoxx Inc.2022-01-04

Track Bionoxx Inc. automatically

Every clearance here is in the API, with alerts when new ones post.